New hope for lymphoma patients: experimental combo trial launched
Disease control
Terminated
This early-stage trial tests a new drug, zanubrutinib, added to a standard chemotherapy cocktail (R-PolaCHP) for people newly diagnosed with diffuse large B-cell lymphoma. The main goal is to find the safest dose and understand side effects. About 38 adults with this type of bloo…
Phase: PHASE1 • Sponsor: Yazeed Sawalha • Aim: Disease control
Last updated May 11, 2026 20:48 UTC